Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Ohashi, Yasuo"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-3 z 3
    Tytuł:
    A randomized phase III study of hepatic arterial infusion chemotherapy with 5-fluorouracil and subsequent systemic chemotherapy versus systemic chemotherapy alone for colorectal cancer patients with curatively resected liver metastases (Japanese Foundation for Multidisciplinary Treatment of Cancer 32).
    Autorzy:
    Kusano M; Kushiro Rosai Hospital, Kushiro, Japan.
    Aoyama T; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
    Okabayashi K; Department of Surgery, Keio University School of Medicine, Tokyo, Japan.
    Hirata K; Department of Surgery, Surgical Oncology and Science, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan.
    Tsuji Y; Hijirigaoka Hospital, Date, Japan.
    Nakamori S; Department of Hepato-Biliary-Pancreatic Surgery, National Hospital Organization Osaka National Hospital, Osaka, Japan.
    Asahara T; Hiroshima University, Hiroshima, Japan.
    Ohashi Y; Department of Biostatistics, School of Public Health, The University of Tokyo, Tokyo, Japan.
    Yoshikawa T; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
    Sakamoto J; Tokai Central Hospital, Kakamigahara, Japan.
    Oba K; Translational Research and Clinical Trial Center, Hokkaido University Hospital, Sapporo, Hokkaido, Japan.
    Saji S; Japanese Foundation for Multidisciplinary Treatment of Cancer, Tokyo, Japan.
    Pokaż więcej
    Źródło:
    Journal of cancer research and therapeutics [J Cancer Res Ther] 2018 Sep; Vol. 14 (Supplement), pp. S761-S766.
    Typ publikacji:
    Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
    MeSH Terms:
    Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
    Colorectal Neoplasms/*drug therapy
    Fluorouracil/*administration & dosage
    Liver Neoplasms/*drug therapy
    Administration, Oral ; Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Colorectal Neoplasms/pathology ; Colorectal Neoplasms/surgery ; Disease-Free Survival ; Female ; Fluorouracil/adverse effects ; Hepatic Artery ; Humans ; Infusions, Intra-Arterial ; Leucovorin/administration & dosage ; Leucovorin/adverse effects ; Liver/drug effects ; Liver/pathology ; Liver/surgery ; Liver Neoplasms/pathology ; Liver Neoplasms/secondary ; Liver Neoplasms/surgery ; Male ; Middle Aged ; Neoplasm Metastasis ; Tegafur/administration & dosage ; Tegafur/adverse effects
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Impact of UGT1A1 genotype upon toxicities of combination with low-dose irinotecan plus platinum.
    Autorzy:
    Takano M; Department of Obstetrics and Gynecology, National Defense Medical College, Tokorozawa, Japan.
    Yamamoto K; Department of Obstetrics and Gynecology, Sakai Hospital, Kinki University Faculty of Medicine, Sakai, Japan.
    Tabata T; Department of Obstetrics and Gynecology, Mie University Graduate School of Medicine, Tsu, Japan.
    Minegishi Y; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
    Yokoyama T; Department of Respiratory Medicine, Kyorin University Hospital, Mitaka, Japan.
    Hirata E; Department of Obstetrics and Gynecology, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.
    Ikeda T; Department of Respiratory Medicine, Naga Municipal Hospital, Kinokawa, Japan.
    Shimada M; Department of Obstetrics and Gynecology, Tottori University School of Medicine, Yonago, Japan.
    Yamada K; Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Japan.
    Morita S; Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
    Ando Y; Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan.
    Hirata K; Pharmacovigilance Department, Daiichi Sankyo, Tokyo, Japan.
    Sugihara M; Clinical Data and Biostatistics Department, Daiichi Sankyo, Tokyo, Japan.
    Sugiyama T; Department of Obstetrics and Gynecology, Iwate Medical University, Morioka, Japan.
    Ohashi Y; Department of Integrated Science and Engineering for Sustainable Society, Chuo University, Tokyo, Japan.
    Sakata Y; CEO, Misawa City Hospital, Misawa, Japan.
    Pokaż więcej
    Źródło:
    Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2016 Jun; Vol. 12 (2), pp. 115-24. Date of Electronic Publication: 2016 Feb 10.
    Typ publikacji:
    Journal Article; Multicenter Study; Observational Study
    MeSH Terms:
    Antineoplastic Combined Chemotherapy Protocols/*adverse effects
    Glucuronosyltransferase/*genetics
    Aged ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Camptothecin/administration & dosage ; Camptothecin/adverse effects ; Camptothecin/analogs & derivatives ; Dose-Response Relationship, Drug ; Female ; Genotype ; Glucuronosyltransferase/metabolism ; Humans ; Irinotecan ; Male ; Middle Aged ; Organoplatinum Compounds/administration & dosage ; Organoplatinum Compounds/adverse effects ; Polymorphism, Single Nucleotide ; Prospective Studies ; Risk Factors
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
      Wyświetlanie 1-3 z 3

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies